Common use of Collaboration Targets Clause in Contracts

Collaboration Targets. GSK shall have the right to extend the Research Term on an annual basis for up to three (3) additional [*] periods beyond Contract Year Five. To exercise such option, GSK shall so notify CK in writing at least [*] ([*]) months prior to the expiration of the Research Term (including any extensions thereof in accordance with this Section 2.8. 1). During any extension of the Research Term under this Section 2.8.1, the Research Plan shall provide for [*] ([*]) CK FTEs, or a higher number if mutually agreed, performing activities with respect to Collaboration Targets under the Research Program, funded by GSK at the FTE rate established under Section 6.2.1 below. It is understood that, during any extension under this Section 2.8, the Research Program shall be limited to research and development activities directed to Collaboration Targets, except as provided under Section 2.8.2 below. In the event that the Research Term ends at any point in time, * Certain information on this page has been omitted and filed separately with the Commission. Confidential treatment has been requested with respect to the omitted portions. then from and after such time GSK shall have no further right to extend the Research Term under this Section 2.8.1.

Collaboration Targets. GSK shall have the right to extend the Research Term on an annual basis for up to three (3) additional [*] one-year periods beyond Contract Year Five. To exercise such option, GSK shall so notify CK in writing at least [*] ([*]) months prior to the expiration of the Research Term (including any extensions thereof in accordance with this Section 2.8. 12.8.1). During any extension of the Research Term under this Section 2.8.1, the Research Plan shall provide for [*] ([*]) CK FTEs, or a higher number if mutually agreed, performing activities with respect to Collaboration Targets under the Research Program, funded by GSK at the FTE rate established under Section 6.2.1 below. It is understood that, during any extension under this Section 2.8, the Research Program shall be limited to research and development activities directed to Collaboration Targets, except as provided under Section 2.8.2 below. In the event that the Research Term ends at any point in time, * Certain information on this page has been omitted and filed separately with the Commission. Confidential treatment has been requested with respect to the omitted portions. then from and after such time GSK shall have no further right to extend the Research Term under this Section 2.8.1.

Collaboration Targets. GSK shall have the right to extend the Research Term on an annual basis for up to three [*](3[*]) additional [*] periods beyond Contract Year Five. To exercise such option, GSK shall so notify CK in writing at least [*] ]([*]) months prior to the expiration of the Research Term (including any extensions thereof in accordance with this Section 2.8. 1). During any extension of the Research Term under this Section 2.8.1, the Research Plan shall provide for [*] ]([*]) CK FTEs, or a higher number if mutually agreed, performing activities with respect to Collaboration Targets under the Research Program, funded by GSK at the FTE rate established under Section 6.2.1 below. It is understood that, during any extension under this Section 2.8, the Research Program shall be limited to research and development activities directed to Collaboration Targets, except as provided under Section 2.8.2 below. In the event that the Research Term ends at any point in time, * Certain information on this page has been omitted and filed separately with the Commission. Confidential treatment has been requested with respect to the omitted portions. then from and after such time GSK shall have no further right to extend the Research Term under this Section 2.8.1.